enzyme-kinetics module of graphpad prism 10.2 (GraphPad Software Inc)
GraphPad Software Inc is a verified supplier 
90
Structured Review
GraphPad Software Inc
enzyme-kinetics module of graphpad prism 10.2
Enzyme Kinetics Module Of Graphpad Prism 10.2, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/enzyme-kinetics+module+of+graphpad+prism+10%2E2/enzyme+kinetics+module+in+graphpad+prism/pm40518052-103-20-23
Average 90 stars, based on 1 article reviews
Enzyme Kinetics Module Of Graphpad Prism 10.2, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/enzyme-kinetics+module+of+graphpad+prism+10%2E2/enzyme+kinetics+module+in+graphpad+prism/pm40518052-103-20-23
Average 90 stars, based on 1 article reviews
enzyme-kinetics module of graphpad prism 10.2 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Repurposing FDA-approved allosteric drugs as non-competitive inhibitors of human UGTs: An integrated computational study and biochemical validation. Article Snippet: UDP-glucuronosyltransferases (UGTs) catalyze a major detoxification route for xenobiotics, yet chemical tools that modulate their activity are virtually absent and the possibility of allosteric regulation is largely unexplored.. We combined ligand-based target prediction, structure-based docking, long-timescale molecular dynamics and MM/PBSA free-energy calculations to search the pharmacopeia for hidden UGT modulators.. Six FDA-approved allosteric drugs were screened against the catalytic domains of UGT1A1, 1A9, 2B7 and 2B15. |